Prolyl endopeptidase (PEP, EC 3.4.21.26) has been proposed to play a role in degradation of proline-containing neuropeptides involved in the processes of learning and memory, e.g., vasopressin, substance P, and thyrotropin-releasing hormone (TRH). In the course of our search for bioactive constituents in medicinal plants, we studied the PEP inhibitory constituents of the roots of Lindera strychnifolia F. VILL and isolated two known tannins, epicatechin (1) and aesculitannin B (2), and four known sesquiterpenes, linderene (3), linderene acetate (4), linderalactone (5) and isolinderalactone (6) as inhibitors. On the inhibitory activities of six compounds against PEP from Flavobacterium meningosepticum and that from rat brain supernatant, compounds 1, 2 and 4 inhibited the enzyme from Flavobacterium more strongly than that from rat brain supernatant. However, compounds 3, 5 and 6 inhibited the enzymes from both origins to the same extent and furthermore, compound 6 was the strongest natural inhibitor against PEP from rat brain supernatant. The kinetic study of these inhibitors indicated that compounds 1, 2 are noncompetitive inhibitors and compounds 3-6 are competitive inhibitors. This is the first example of non-phenolic constituents showing significant competitive inhibitory activity being isolated from natural medicines.
Prolyl endopeptidase (PEP, EC 3.4.21.26) is a serine protease cleaving peptide bond at the carboxyl side of proline residues and was first isolated as an oxytocin-inactivating enzyme from the human uterus. 1) This enzyme is distributed in a wide range of species, especially in human brain. 2) In the central nervous system, PEP degrades proline-containing neuropeptides involved in the processes of learning and memory, e.g., vasopressin, substance P, and thyrotropin-releasing hormone (TRH), 3, 4) and abnormal levels of PEP activity are associated with neurodegenerative disorders. 5, 6) In addition, PEP-like immunoreactivity was detected in the hippocampus of senescence-accelerated mouse, 7) and the PEP activity of Alzheimer's patients was significantly higher than the control. 8) Thus specific inhibitors for PEP are believed to have anti-amnesic effects 9) and many inhibitors have been chemically synthesized or identified from natural resources. 10) In general, almost all PEP inhibitors derived from natural medicines are phenolic compounds containing a catechol or pyrogallol group, and there is no report concerning the actions of natural inhibitors against bacterial or mammalian enzymes. [11] [12] [13] [14] So we developed a screening for PEP inhibitors from natural medicines in order to identify non-phenolic inhibitors from natural medicines and to determine the inhibitory potency against PEP originating from a bacterium and a mammal. After the PEP inhibition test of 129 kinds of natural medicines, we found that a MeOH extract of the roots of Lindera strychnifolia showed significant inhibitory activity. L. strychnifolia (Lauraceae) is widely distributed in Japan and the People's Republic of China and its roots, Linderae Radix, are used as a traditional medicine as an analeptic, an analgesic and a digestive. 15) From the roots of L. strychnifolia, monoterpenes, sesquiterpenes and alkaloids were reported but phenolic constituents such as tannins, have not been reported so far. 16, 17) Thus we studied the PEP inhibitory constituents of the roots of L. strychnifolia and isolated four known sesquiterpenes and two known tannins. In this paper, we report the isolation and structural identification of the constituents of the roots of L. strychnifolia and inhibitory activity against PEP from Flavobacterium and rat brain supernatant.
MATERIALS AND METHODS

General
1 H-(400 MHz) and 13 C-NMR (100 MHz) spectra were recorded on a JEOL a-400 FT-NMR spectrometer with tetramethylsilane as an internal standard. Positive-mode FAB-MS were recorded on a JEOL JMS-SX102 spectrometer, using a m-nitrobenzyl alcohol matrix. HPLC was performed using a JASCO System 800. PEP activity was measured with a Tosoh MPR-A4i II microplate reader and a BIO-TEK FL500.
Materials PEP (Flavobacterium meningosepticum origin) was purchased from Seikagaku Co. (Tokyo, Japan). ZGly-Pro-pNA and Z-Gly-Pro-AMC were purchased from Bachem Fine Chemical Co. (Switzerland). Z-Pro-prolinal was purchased from Biomol Research Laboratories Co. (U.S.A.), and brain samples from male Wistar rats were purchased from Funakoshi Co. (Tokyo). Epigallocatechin gallate (EGCG) was isolated in our laboratory.
PEP Inhibition Assay (Flavobacterium meningosepticum) PEP activity was assayed by the method of Yoshimoto et al., 18) in which 840 ml of 0.1 M phosphate buffer (pH 7.0), 50 ml of 0.1 unit/ml PEP in 50 mM phosphate buffer (pH 7.0) and 10 ml test sample solution in EtOH were mixed and pre-incubated for 5 min at 30°C. The reaction was started by adding 100 ml of 2 mM Z-Gly-Pro-pNA in 40% 1,4-dioxane. After incubation at 30°C for 30 min, 500 ml of 1 M acetate buffer (pH 4.0) was added and the absorbance of the solution was measured at 415 nm. The percentage of inhibition can be calculated from the absorbance with (A) and without (B) May 7, 2002 [(BϪA)/B]ϫ100.
PEP Inhibition Assay (Rat Brain Supernatant) PEP activity was measured by a modification of the method of Kato et al. 19) In brief, the brain of a rat was homogenized in 3 volumes of 0.1 M phosphate buffer (pH 7.0). After centrifugation at 10000ϫg for 20 min, the supernatant was used for the enzyme assay. The PEP activity of this enzyme solution was 1.17ϫ10
Ϫ2 unit/mg protein. Ten microliters of enzyme solution was pre-incubated with 960 ml of 0.1 M phosphate buffer (pH 7.0) and 10 ml of test sample solution in EtOH at 30°C for 5 min. The reaction was initiated by adding 20 ml of 2 mM Z-Gly-Pro-AMC and incubated at 30°C for 30 min. The reaction was stopped by adding 2 ml of 1 M acetate buffer (pH 4.0), and the fluorescence intensity of the solution was measured at 460 nm with excitation at 360 nm. The percentage of inhibition can be calculated from the fluorescence intensity with (A) and without (B) inhibitor, by the following equation: Percentage of inhibitionϭ[(BϪA)/B]ϫ100.
PEP Inhibitory Activity of Natural Medicines The PEP inhibitory activities of 129 kinds of natural, mainly traditional anti-amnesic medicines, stimulants and tonics, were examined. As shown in Table 1 , sixteen natural medicines showed significant PEP inhibitory activity. Among them, twelve, excluding Epimedium grandiflorum, Lindera strychnifolia, Momordica cochinchinensis and Polygala tenuifolia, were reported to contain phenolic compounds. 20, 21) There are many reports concerning the PEP inhibitory activity of phenolic compounds, [11] [12] [13] [14] and it is known that tannins interact with proteins and inhibit various enzymes. 20) So it seemed that the PEP inhibitory activities of these twelve natural medicines were caused by phenolic compounds. The PEP inhibitory activities of the other four natural medicines were investigated, and that of L. strychnifolia was the strongest, so we studied the PEP inhibitory constituents of the roots of L. strychnifolia.
Extraction and Fractionation The commercial avail- 
Separation of CHCl 3 Soluble Fraction
The CHCl 3 soluble fraction (50 g) was suspended in 80% MeOH aq. and extracted with hexane-benzene (1 : 1). Each layer was evaporated in vacuo to give an 80% MeOH aq. layer (27 g, IC 50 ϭ 32.6 mg/ml) and a hexane-benzene (1 : 1) layer (21 g, IC 50 ϭ 3.9 mg/ml). The hexane-benzene (1 : 1) layer (20 g) was chromatographed on alumina (25 g) column and eluted with CHCl 3 , MeOH and AcOH-MeOH (5 : 95), successively. Each eluate was concentrated in vacuo to give CHCl 3 eluate (13 g, IC 50 ϭ3.2 mg/ml), MeOH eluate (1.0 g, IC 50 ϭ42.1 mg/ml) and AcOH-MeOH (5 : 95) eluate (5.1 g, IC 50 ϭ22.6 mg/ml). The CHCl 3 eluate (6.0 g) was subjected to preparative HPLC [ODS 5ϫ100 cm; CH 3 CN-H 2 O (47 : 53)→(63 : 37) linear gradient and CH 3 CN] to afford fractions a-h. Fractions c-f showed significant PEP inhibitory activity and faction c was identified as linderalctone (5, 330 mg), fraction d as linderene (3, 218 mg), fraction e as isolinderalactone (6, 
RESULTS AND DISCUSSION
In the course of our search for bioactive constituents in medicinal plants, we examined PEP inhibitory constituents of the roots of L. strychnifolia and isolated six known compounds 1-6 as inhibitors. Compound 1 was determined to be epicatechin by direct comparison with authentic sample, and the others were identified by comparison of spectral data with reported data as aesculitannin B (2), linderene (3), linderene acetate (4), linderalactone (5) and isolinderalactone (6) (Fig. 1) . Compounds 3-6 were earlier reported to be constituents of the roots of L. strychnifolia, but this was the first time tannins 1 and 2 were isolated from this plant. 16) PEP suggests that there is no difference among mammalia, 23) but there are some differences between bacteria and mammalia, e.g., isoelectric point and sensitivity to pchloromercuribenzoic acid (PCMB). 18) In addition, bacterial (Flavobacterium) and mammalian (bovine brain) enzyme genes were cloned and their amino acid sequences had 48% identity 24) ; we therefore investigated the inhibitory activities of six compounds by two different assays. One is the method of Yoshimoto et al., 9) which is the most popular Flavobacterium PEP inhibition assay, and the other is the method of Kato et al., 19) which measures inhibitory activity against PEP from rat brain supernatant. The concentrations of these compounds causing 50% inhibition are shown in Table 2 , together with the positive controls, EGCG and Z-Pro-prolinal. Compound 1 is a known inhibitor against PEP from Flavobacterium, 13) however, compounds 2-6 are new PEP inhibitors. Against PEP from Flavobacterium, compound 2 showed the same inhibitory effect as other tannins reported to date, [11] [12] [13] [14] and compounds 3-6 were first examples of sesquiterpenic inhibitors. Compound 6 showed significant inhibitory activity as a non-phenolic compound. Against PEP from rat brain supernatant, all compounds including positive controls showed weak inhibition, in comparison with Flavobacterium PEP inhibitory activity, and those of the tannins 1, 2 and EGCG, declined considerably. It seemed that these results were caused by tannins interacting with other proteins in rat brain supernatant or tannins inhibiting only Flavobacterium PEP specifically but not inhibiting mammalian PEP. However, interestingly, these sesquiterpenic inhibitors exhibit little differences in PEP inhibitory activity between Flavobacterium and rat brain supernatant and compound 6 was the strongest natural inhibitor in this report.
On the other hand, the inhibition mode of almost all nonpeptidic inhibitors is noncompetitive and the only competitive inhibitor from natural sources is protocatechuic acid.
11)
Lineweaver-Burk plots for these inhibitors obtained from the roots of L. strychnifolia indicated that conpounds 1 and 2 were noncompetitive inhibitors, but interestingly, compounds 3-6 showed competitive inhibition; Lineweaver-Burk plots of 6 are shown in Fig. 2 . These sesquiterpenes are thus considered new type of inhibitors in contrast to non-phenolic competitive inhibitors.
L. strychnifolia belongs to the family Lauraceae and its roots are used as an analeptic, an analgesic and a digestive. These roots are proposed to improve palsy and prevent stroke, 15) however, the principles of these medicinal effects are not yet clear. In this paper, we reported that the roots of L. strychnifolia showed significant PEP inhibitory activity. It is inferred that constituents of these roots inhibit PEP and contribute to its medicinal effects. On the other hand, most of the PEP inhibitors reported so far are synthetic substrate mimetics and only a few have been reported from natural sources. 10) Almost all PEP inhibitors from medicinal plants are phenolic compounds, and there has been no report concerning a natural inhibitor which is not a peptide or a phenolic compound. [10] [11] [12] [13] [14] In this paper, we reported six PEP inhibitors from the roots of L. strychnifolia, compounds 3-6 among them being non-phenolic inhibitors. Compound 6 showed strong competitive inhibitory activity against PEP both from Flavobacterium and from rat brain supernatant. These sesquiterpenes are also lipophilic compounds. Since PEP is an intracellular enzyme and distributed in brain, these characteristics are meaningful for a PEP inhibitor. These re- 
